Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
2.380
-0.060 (-2.46%)
At close: Mar 14, 2025, 4:00 PM
2.390
+0.010 (0.42%)
After-hours: Mar 14, 2025, 7:45 PM EST
Allurion Technologies Revenue
Allurion Technologies had revenue of $5.37M in the quarter ending September 30, 2024, a decrease of -70.51%. This brings the company's revenue in the last twelve months to $34.75M, down -46.05% year-over-year. In the year 2023, Allurion Technologies had annual revenue of $53.47M, down -16.73%.
Revenue (ttm)
$34.75M
Revenue Growth
-46.05%
P/S Ratio
0.14
Revenue / Employee
$68,956
Employees
504
Market Cap
17.14M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 53.47M | -10.74M | -16.73% |
Dec 31, 2022 | 64.21M | 25.97M | 67.91% |
Dec 31, 2021 | 38.24M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALUR News
- 2 days ago - Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025 - Business Wire
- 10 days ago - Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity - Business Wire
- 17 days ago - Allurion to Participate in Upcoming Investor Conferences - Business Wire
- 22 days ago - Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline - Business Wire
- 23 days ago - Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline - Business Wire
- 24 days ago - Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity - Business Wire
- 4 weeks ago - Allurion Relaunches in France - Business Wire
- 7 weeks ago - Allurion Technologies Shares Are Up Today: What's Going On? - Benzinga